$AMPX

Amprius Technologies, Inc.

CIK:0001899287|SEC Filings

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenue	$ 34,032	$ 15,067	$ 62,568	$ 26,351
Cost of revenue	24,752	13,727	47,548	27,372
Gross profit (loss)	9,280	1,340	15,020	(1,021)
Operating expenses:
Research and development	4,099	2,162	7,898	4,165
Selling, general and administrative	9,479	5,991	18,107	11,298
Total operating expenses	13,578	8,153	26,005	15,463
Loss from operations	(4,298)	(6,813)	(10,985)	(16,484)
Other income, net	1,144	443	2,785	743
Net loss	(3,154)	(6,370)	(8,200)	(15,741)
Increase in net loss due to warrant modification	(1,921)	0	(1,921)	0
Net loss attributable to common stockholders	(5,075)	(6,370)	(10,121)	(15,741)
Net loss attributable to common stockholders	$ (5,075)	$ (6,370)	$ (10,121)	$ (15,741)
Weighted-average common shares outstanding:
Weighted-average common shares outstanding, basic (in shares)	143,469,187	121,783,506	140,226,126	119,854,678
Weighted-average common shares outstanding, diluted (in shares)	143,469,187	121,783,506	140,226,126	119,854,678
Net loss per share of common stock:
Net loss per share of common stock, basic (in dollars per share)	$ (0.04)	$ (0.05)	$ (0.07)	$ (0.13)
Net loss per share of common stock, diluted (in dollars per share)	$ (0.04)	$ (0.05)	$ (0.07)	$ (0.13)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities:
Net loss	$ (8,200)	$ (15,741)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	4,599	3,728
Depreciation and amortization	1,512	1,961
Loss on termination of lease	166	0
Write-down of property, plant and equipment	77	0
Non-cash operating lease expense	928	2,571
Gain on disposal of property, plant and equipment	(355)	0
Other non-cash items	(22)	818
Changes in operating assets and liabilities:
Accounts receivable, net	(16,843)	(6,005)
Inventories	(4,774)	2,240
Prepaid expenses and other current assets	594	(911)
Other assets	(11)	20
Accounts payable	2,501	(3,809)
Accrued and other current liabilities	288	(758)
Deferred revenue	312	(798)
Operating lease liabilities	(20,898)	(1,707)
Net cash used in operating activities	(40,126)	(18,391)
Cash flows from investing activities:
Purchase of property, plant and equipment	(2,799)	(1,629)
Proceeds from the disposal of property, plant and equipment	355	0
Net cash used in investing activities	(2,444)	(1,629)
Cash flows from financing activities:
Proceeds from exercise of warrants	14,182	0
Proceeds from exercise of stock options	11,221	1,066
Net cash provided by financing activities	25,403	19,261
Net decrease in cash, cash equivalents and restricted cash equivalents	(17,167)	(759)
Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents	19	(7)
Cash, cash equivalents and restricted cash equivalents, beginning of period	91,921	56,411
Cash, cash equivalents and restricted cash equivalents, end of period	74,773	55,645
Reconciliation of cash, cash equivalents and restricted cash equivalents shown on the condensed consolidated balance sheets:
Cash and cash equivalents	74,517	54,189
Restricted cash equivalents included in prepaid expenses and other current assets	200	200
Restricted cash equivalents included in other assets	56	1,256
Total cash, cash equivalents and restricted cash equivalents	74,773	55,645
Supplemental non-cash investing and financing activities:
Unpaid purchases of property, plant and equipment	1,141	174
Right-of-use asset and operating lease obligations from new lease	105	0
Right-of-use assets derecognized in connection with lease termination	13,362	0
At Market Issuance Sales Agreement
Cash flows from financing activities:
Proceeds from issuance of common stock in connection with the At Market Issuance Sales Agreement, net	$ 0	$ 18,195

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 74,517	$ 90,465
Accounts receivable, net	40,650	23,737
Inventories	11,510	6,735
Prepaid expenses and other current assets	4,907	5,500
Total current assets	131,584	126,437
Non-current assets:
Property, plant and equipment, net	11,710	9,680
Operating lease right-of-use assets, net	5,826	19,518
Other assets	63	1,256
Total assets	149,183	156,891
Current liabilities:
Accounts payable	9,760	6,700
Accrued and other current liabilities	4,259	3,666
Deferred grant	2,738	2,738
Deferred revenue	413	100
Operating lease liabilities	1,181	4,665
Total current liabilities	18,351	17,869
Non-current liabilities:
Operating lease liabilities	5,196	35,207
Total liabilities	23,547	53,076
Commitments and contingencies (Note 10)
Stockholders’ equity:
Preferred stock; $0.0001 par value; 50,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock; $0.0001 par value; 950,000,000 shares authorized; 146,080,618 and 134,536,592 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively	14	13
Additional paid-in capital	352,157	322,156
Accumulated other comprehensive income	23	4
Accumulated deficit	(226,558)	(218,358)
Total stockholders’ equity	125,636	103,815
Total liabilities and stockholders’ equity	$ 149,183	$ 156,891